{
  "meta": {
    "id": "test33",
    "title": "Hematology-Chronic_Myeloid_Leukemia",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 60-year-old male patient presents to his family physician with complaints of fatigue, malaise, and unintentional weight loss for the past 6 months. On examination, the patient appears pale, and there is splenomegaly. The blood picture reveals anaemia, leukocytosis, and basophilia. Upon suspicion, genetic testing was done, and a diagnosis was made. Which of the following is the underlying genetic defect in this condition?",
      "options": [
        {
          "label": "A",
          "text": "Translocation between chromosomes 12 and 21",
          "correct": false
        },
        {
          "label": "B",
          "text": "Unbalanced translocation between the long arm of chromosomes 9 and 22",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deletion of chromosomes 11q, 13q, 17p",
          "correct": false
        },
        {
          "label": "D",
          "text": "Balanced translocation between the long arms of chromosomes 9 and 22",
          "correct": true
        }
      ],
      "correct_answer": "D. Balanced translocation between the long arms of chromosomes 9 and 22",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/ubjfUdjgnTMSWByZT6yM1744697921.png",
        "https://image.prepladder.com/notes/Tu46dTeOSzd38UJYk3I81744698080.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "822287ed"
    },
    {
      "text": "Which of the following statements regarding the genetic basis of Chronic Myeloid Leukemia (CML) is most accurate?",
      "options": [
        {
          "label": "A",
          "text": "The BCR-ABL fusion gene in CML results from a translocation involving chromosomes 15 and 17.",
          "correct": false
        },
        {
          "label": "B",
          "text": "CML patients who progress to blast crisis often acquire mutations in the TP53 gene, leading to genomic instability.",
          "correct": true
        },
        {
          "label": "C",
          "text": "The BCR-ABL fusion protein activates the JAK-STAT signalling pathway, contributing to leukemic cell proliferation in CML.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resistance to tyrosine kinase inhibitors (TKIs) in CML is commonly associated with mutations in the BCR gene.",
          "correct": false
        }
      ],
      "correct_answer": "B. CML patients who progress to blast crisis often acquire mutations in the TP53 gene, leading to genomic instability.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:743px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:bottom\">\n<p style=\"text-align: center;\"><strong>Genetic Abnormality</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:bottom\">\n<p style=\"text-align: center;\"><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>Philadelphia <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">Chromosome</span> (Ph)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p>A <strong>reciprocal <span class=\"customMeta\" data-dictid=\"8ba7332e86169277720060bd4507c8\">translocation</span> between chromosomes 9 and 22 [t(9;22)]</strong>, resulting in the <strong>fusion of the BCR gene </strong>on <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> 22 with the<strong> ABL gene </strong>on <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> 9 <strong>(Option A ruled out).</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>BCR-ABL <span class=\"customMeta\" data-dictid=\"a7dfeb385e1692777203302bcf142d\">Fusion</span> Gene</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p>The <span class=\"customMeta\" data-dictid=\"a7dfeb385e1692777203302bcf142d\">fusion</span> of BCR and ABL genes leads to a constitutively active tyrosine <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> (BCR-ABL) that promotes uncontrolled cell <span class=\"customMeta\" data-dictid=\"8eedb6cec61692777196a6a3b93d3f\">proliferation</span> and survival in CML.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>ABL <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">Kinase</span> Domain Mutations</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p>Mutations within the ABL <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> domain, particularly T315I, are associated with <strong>resistance to tyrosine <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> inhibitors (TKIs)</strong> used in <span class=\"customMeta\" data-dictid=\"32c39405871692777184d06d6c01ab\">CML</span> treatment.\u00a0<strong>(Option D\u00a0ruled out).</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>JAK-STAT <span class=\"customMeta\" data-dictid=\"f9016f36fd1692777198b0fd5e9c6d\">Signaling</span> Pathway</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p>Although not directly activated by BCR-ABL, <strong>JAK-STAT <span class=\"customMeta\" data-dictid=\"3aa5abc2fa169277719488e088076d\">pathway</span> dysregulation</strong> may contribute to <span class=\"customMeta\" data-dictid=\"32c39405871692777184d06d6c01ab\">CML</span> pathogenesis, including disease <span class=\"customMeta\" data-dictid=\"3c305b384216927771969ca4166493\">progression</span> and resistance.\u00a0<strong>(Option C\u00a0ruled out).</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>TP53 Mutations</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #e3e3e3; border-left:1px solid #e3e3e3; border-right:1px solid #e3e3e3; border-top:1px solid #e3e3e3; vertical-align:middle\">\n<p><strong>Acquired mutations in TP53</strong>, common in <span class=\"customMeta\" data-dictid=\"c961b3ec6516927771831836e7f351\">blast crisis</span> CML, lead to genomic instability, <span class=\"customMeta\" data-dictid=\"5173f9c96716927771843cbe0c7611\">cell cycle</span> dysregulation, and aggressive disease behaviour.</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "d9e4e8ca"
    },
    {
      "text": "A 55-year-old male presents with fatigue, weight loss and abdominal discomfort. On physical examination, the spleen is palpable 5 cm below the left costal margin, and there is mild tenderness in the left upper quadrant. Blood investigations reveal anaemia, leukocytosis, and basophilia. Which of the following features is not associated with this condition?",
      "options": [
        {
          "label": "A",
          "text": "Pruritus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diarrhea",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased NAP score",
          "correct": true
        },
        {
          "label": "D",
          "text": "Left shift in differential count",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased NAP score",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:635px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Age group </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>55-65 years or older.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Anemia</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Fatigue, malaise, weight loss (10% in 6 months).</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Splenomegaly</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Early satiety, left upper <span class=\"customMeta\" data-dictid=\"3a757d7c1216927771968223be411d\">quadrant</span> pain/mass.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Thrombotic or hyperviscosity-related symptoms</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Priapism</li>\n<li>Cardiovascular complications</li>\n<li>Visual disturbances</li>\n<li>Dyspnea</li>\n<li>Pulmonary insufficiency</li>\n<li>Cerebrovascular complications</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Bleeding diathesis</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Retinal hemorrhage</li>\n<li>Gastrointestinal hemorrhage</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Progression to accelerated or blast phase</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Unexplained significant weight loss</li>\n<li>Severe fatigue</li>\n<li>Bone and joint pain</li>\n<li>Bleeding and thrombotic events</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Basophilia </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Causes excessive <span class=\"customMeta\" data-dictid=\"b5d4ddbfe71692777189a12acd5502\">histamine</span> production, leading to:</p>\n<ul>\n<li><strong>Pruritus </strong><strong>(Option A)</strong></li>\n<li><strong>Diarrhea </strong><strong>(Option B)</strong></li>\n<li>Flushing</li>\n<li>Gastrointestinal ulcers</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:619px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Decreased <span class=\"customMeta\" data-dictid=\"dd4fbf70c41692777193f9cc6697e6\">NAP</span> score</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Increased <span class=\"customMeta\" data-dictid=\"dd4fbf70c41692777193f9cc6697e6\">NAP</span> score</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Paroxysmal <span class=\"customMeta\" data-dictid=\"d51601f2c41692777193ddfa55d163\">nocturnal</span> <span class=\"customMeta\" data-dictid=\"ddeb334a351692777188795bb090ef\">hemoglobinuria</span> (PNH)</li>\n<li>Myelodysplastic syndrome</li>\n<li><strong>CML</strong></li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Stress</li>\n<li>Infection</li>\n<li>Leukemoid reaction</li>\n<li>Pregnancy</li>\n<li>Other <span class=\"customMeta\" data-dictid=\"8dd789d7d1169277719303d4744837\">myeloproliferative</span> disorders except CML</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "fb325a80"
    },
    {
      "text": "A 60-year-old male presents with fatigue, malaise, weight loss, and swelling in the left upper quadrant of the abdomen. On evaluation, he was diagnosed with chronic myeloid leukaemia. Which of the following peripheral smears will be seen in this patient?",
      "options": [
        {
          "label": "A",
          "text": "No options available",
          "correct": true
        }
      ],
      "correct_answer": "A. No options available",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/tMaEkozF09i4mVr2ZejF1744699736.png",
        "https://image.prepladder.com/notes/xO9bBDiLD6HaR3SOYTAG1744699860.png",
        "https://image.prepladder.com/notes/ED4K81uoq9nfgEIMFitY1744699964.png",
        "https://image.prepladder.com/notes/ozMPSWKh38SHq30wD11q1744700045.png"
      ],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Cell </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Myeloblast</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Large cells with a round or <span class=\"customMeta\" data-dictid=\"74793d564816927771943ae4ba74b3\">oval</span> <span class=\"customMeta\" data-dictid=\"ff628904401692777193c8a9f9159e\">nucleus</span> with dark <span class=\"customMeta\" data-dictid=\"728bb228361692777185b98c34534b\">cytoplasm</span> and no granules.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Segmented neutrophil</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Has a <span class=\"customMeta\" data-dictid=\"ff628904401692777193c8a9f9159e\">nucleus</span> with 2-5 lobes.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Myelocyte</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>The <span class=\"customMeta\" data-dictid=\"ff628904401692777193c8a9f9159e\">nucleus</span> is <span class=\"customMeta\" data-dictid=\"74793d564816927771943ae4ba74b3\">oval</span> and eccentrically placed.(D-shaped nuclei)</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Metamyelocyte</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Has a <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> bean-shaped nucleus.</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "3b4e7e70"
    },
    {
      "text": "A 58-year-old male is diagnosed with chronic myeloid leukemia (CML). The oncologist is planning to monitor the patient\u2019s response to treatment and check for the presence of the Philadelphia chromosome. What is the investigation of choice for confirming the diagnosis of CML and detecting the Philadelphia chromosome?",
      "options": [
        {
          "label": "A",
          "text": "Bone marrow examination",
          "correct": false
        },
        {
          "label": "B",
          "text": "FISH (Fluorescence In Situ Hybridization)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cytogenetic analysis (karyotyping)",
          "correct": false
        },
        {
          "label": "D",
          "text": "PCR (Polymerase Chain Reaction)",
          "correct": false
        }
      ],
      "correct_answer": "B. FISH (Fluorescence In Situ Hybridization)",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/VOpY4sGjrbPzoudkiYq51744700705.png"
      ],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:664px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>CBC</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Normal <span class=\"customMeta\" data-dictid=\"8790b4667016927771979066e8958c\">RBC</span> + Elevated <span class=\"customMeta\" data-dictid=\"15d4ce5bf21692777200543fdf4d2f\">TLC</span> + Elevated platelets</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Peripheral smear</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Left shift with predominant segmented neutrophils, myelocytes, and metamyelocytes.</li>\n<li>College girl/garden party appearance.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Bone <span class=\"customMeta\" data-dictid=\"c8a8c935a41692777191610f6aacb4\">marrow</span> aspirate</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>Increased</strong> Myeloid:Erythroid ratio.</li>\n<li><strong>Dwarf megakaryocytes.</strong></li>\n<li><strong>Sea blue histiocytes</strong> (blue-coloured cytoplasm)</li>\n<li><strong>Pseudo Gaucher cells</strong></li>\n</ul>\n<figure class=\"caption_element\"><img alt=\"Bone <span class=\" custommeta\"=\"\" data-dictid=\"c8a8c935a41692777191610f6aacb4\"/>marrow <span class=\"customMeta\" data-dictid=\"a246c8382816927771821a267ea486\">aspirate</span> CML\" data-author=\"G\u00f6ren \u015eahin D, \u00dcsk\u00fcdar Teke H, Karag\u00fclle M, And\u0131\u00e7 N, G\u00fcnd\u00fcz E, I\u015f\u0131ksoy S, Bali\u0107 M, Akay OM \" data-hash=\"10358\" data-license=\"CC BY 2.5\" data-source=\"https://openi.nlm.nih.gov/detailedresult?img=PMC4454064_TJH-31-428-g1&query=pseudo%20gaucher%20cells&it=xg&req=4&npos=1\" data-tags=\"April2025\" height=\"324\" src=\"https://image.prepladder.com/notes/Ldg2zFJjiBGhBKJNCQu41744700618.png\" width=\"394\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n</figure>\n<p>The image shows Pseudo-Gaucher cells</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>NAP/LAP score</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Decreased</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>FISH (IOC) </strong><strong>(Option B)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Confirms t(9:22) translocation</li>\n<li>Analysis to quantify Philadelphia chromosome-positive cells</li>\n<li>Estimates the tumor load</li>\n</ul>\n<figure class=\"caption_element\"><img alt=\"FISH CML\" data-author=\"Asif M, Jamal MS, Khan AR, Naseer MI, Hussain A, Choudhry H, Malik A, Khan SA, Mahmoud MM, Ali A, Iram S, Kamran K, Iqbal A, Abduljaleel Z, Pushparaj PN, Rasool M\" data-hash=\"10359\" data-license=\"CC BY 4.0\" data-source=\"https://openi.nlm.nih.gov/detailedresult?img=PMC4885335_fonc-06-00124-g002&query=bcr%20abl%20fusion%20gene&it=xg&lic=by&req=4&npos=74\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/VOpY4sGjrbPzoudkiYq51744700705.png\">\n<figcaption>{{caption_text}}</figcaption>\n</img></figure>\n<p>The image shows BCR-ABL gene <span class=\"customMeta\" data-dictid=\"a7dfeb385e1692777203302bcf142d\">fusion</span> (red + green) in <span class=\"customMeta\" data-dictid=\"da0e2a00fa1692777202d6e2054b26\">fluorescence</span> in-situ <span class=\"customMeta\" data-dictid=\"7ac003b8c41692777189e14eda8f2d\">hybridization</span> (FISH; the ABL gene is red and the BCR gene is green).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>PCR </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>To quantify BCR-ABL-1</li>\n<li>It can be a false negative or false positive</li>\n<li>False negative: Early part of the disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "0f27f4a6"
    },
    {
      "text": "A 62-year-old male with a history of chronic myeloid leukemia (CML), diagnosed two years ago and currently on imatinib therapy, presents with worsening fatigue, abdominal discomfort, and early satiety. On examination, he has splenomegaly and mild pallor. Lab tests show hemoglobin 9.5 g/dL, platelet count 90,000/\u00b5L, white blood cell count 50,000/\u00b5L, and 12% blasts on peripheral smear. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Blast crisis of CML",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transformation to acute myeloid leukaemia (AML)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Accelerated phase of CML",
          "correct": true
        },
        {
          "label": "D",
          "text": "Chronic phase of CML",
          "correct": false
        }
      ],
      "correct_answer": "C. Accelerated phase of CML",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:70%\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Chronic phase (M/C) </strong><strong>(Option D)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Accelerated phase (Option C)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Blast phase </strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Leukocytosis: <span class=\"customMeta\" data-dictid=\"98bbe8f3ce1692777183eb722de38e\">Bimodal</span> distribution with a higher proportion of <span class=\"customMeta\" data-dictid=\"0472620c171692777192c655af9c57\">mature</span> segmented neutrophils and myelocytes.</li>\n<li>Blast cells <strong><10%.</strong></li>\n<li>Increased basophils and eosinophils.</li>\n<li>Monocytosis <3%.</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Occurs in 50% of the patients who present with increasing anaemia, thrombocytopenia, and splenomegaly.</li>\n<li>Blast count: <strong>10-19%</strong>.</li>\n<li>Basophilia >20%.</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>CML transforming into <span class=\"customMeta\" data-dictid=\"9ab5f0308116927771814e1fcc72d6\">AML</span> <strong>(Option B)</strong></li>\n<li>Occurs in an average of 3 years after the diagnosis of CML.</li>\n<li>Blasts on the <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> <strong>>20%.</strong></li>\n<li>Presence of <span class=\"customMeta\" data-dictid=\"0ba1f7edfa1692777187ae6f51e603\">extramedullary</span> <span class=\"customMeta\" data-dictid=\"42eb51d31e1692777183d170489ba8\">blastic</span> infiltrates.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "dbab29c2"
    },
    {
      "text": "A 58-year-old male with chronic myeloid leukemia (CML) was diagnosed six months ago and is currently on 400 mg of imatinib daily. His laboratory studies show a quantitative polymerase chain reaction (qPCR) for a BCR-ABL transcript level of 0.02% on the International Scale (IS). What is the most appropriate next step in managing this patient?",
      "options": [
        {
          "label": "A",
          "text": "Increase the dose of imatinib to 600 mg daily",
          "correct": false
        },
        {
          "label": "B",
          "text": "Obtain a bone marrow biopsy and cytogenetic analysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Continue the current dose of imatinib and monitor qPCR every 3 months",
          "correct": true
        },
        {
          "label": "D",
          "text": "Switch to a second-generation tyrosine kinase inhibitor (TKI) such as dasatinib or nilotinib",
          "correct": false
        }
      ],
      "correct_answer": "C. Continue the current dose of imatinib and monitor qPCR every 3 months",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/8tDEB4XAZqt9Fdnn7zy91744700968.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "a228cef4"
    },
    {
      "text": "Which of the following best describes the mechanism of action of imatinib in the treatment of chronic myeloid leukaemia (CML)?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of BCL-2, leading to apoptosis of leukemic cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibition of BCL-2, leading to apoptosis of leukemic cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Blockade of aberrant tyrosine kinase signaling",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stimulation of DNA repair mechanisms, enhancing leukemic cell survival",
          "correct": false
        }
      ],
      "correct_answer": "C. Blockade of aberrant tyrosine kinase signaling",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/9Wj6Pp1dMmUdZmIQuoOe1744701149.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "a2a16260"
    },
    {
      "text": "A 52-year-old male with chronic myeloid leukemia (CML) presents to the emergency department with severe weakness, nausea, and decreased urine output for the past 24 hours, following a new chemotherapy regimen. Lab studies show: Potassium - 6.2 mmol/L, Phosphorus - 7.8 mg/dL, Calcium - 6.5 mg/dL, uric acid - 12 mg/dL, and Creatinine - 2.2 mg/dL. What is the most appropriate initial management for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous hydration and diuretics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous hydration, rasburicase, and diuretics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Intravenous hydration and calcium gluconate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intravenous hydration, loop diuretics, and sodium bicarbonate",
          "correct": false
        }
      ],
      "correct_answer": "B. Intravenous hydration, rasburicase, and diuretics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "83095fea"
    },
    {
      "text": "A 50-year-old male with Chronic Myeloid Leukemia (CML) presents with disease progression while on first-line therapy with imatinib. Molecular testing reveals the presence of the T315I mutation within the ABL kinase domain. What is the most appropriate next step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Continue imatinib therapy at a higher dose.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Switch to a second-generation tyrosine kinase inhibitor (TKI) such as dasatinib or nilotinib.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Consider allogeneic hematopoietic stem cell transplantation (allo-HSCT)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Initiate treatment with ponatinib.",
          "correct": true
        }
      ],
      "correct_answer": "D. Initiate treatment with ponatinib.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p>Correct answer:D) Initiate treatment with ponatinib</p>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:704px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>AGENT</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>APPROVED INDICATIONS </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>NOTABLE TOXICITIES</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Imatinib (Gleevec)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>All phases</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Fluid retention, weight gain, nausea, diarrhea, skin rashes, <span class=\"customMeta\" data-dictid=\"5b1b31d3e41692777195670afc94ca\">periorbital</span> edema, bone or muscle aches and fatigue</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Dasatinib </strong>(2nd generation)<strong> </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>All phases</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Myelosuppression, pleural and <span class=\"customMeta\" data-dictid=\"85bd8b2ec816927771958f9ebe3568\">pericardial</span> effusions , <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> hypertension</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Nilotinib </strong>(2nd generation)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>All phases except <span class=\"customMeta\" data-dictid=\"42eb51d31e1692777183d170489ba8\">blastic</span> phase</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Diabetes , arterio-occlusive disease , pancreatitis</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Bosutinib</strong> (2nd generation)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>All phases</p>\n<p>Most effective in case of imatinib-resistant CML</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Diarrhea , liver <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> , <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> dysfunction</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Ponatinib </strong>(3rd generation)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Optimal TKI if T315I mutation</p>\n<p>Failure of \u2265 2 TKI\u2019s</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Skin rashes, pancreatitis, arterio-occlusive disease, <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> hypertension</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Omacetaxine mepesuccinate</strong> (3rd generation)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Failure of \u2265 2 TKI\u2019s</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Myelosuppression</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "62c20fc3"
    },
    {
      "text": "A 57-year-old male is diagnosed with chronic myeloid leukemia (CML) after presenting with fatigue, night sweats, and splenomegaly. His initial laboratory tests show a white blood cell count of 85,000/\u00b5L, hemoglobin of 10.5 g/dL, and a platelet count of 600,000/\u00b5L. The oncologist decides to evaluate his prognosis to guide treatment decisions. Which of the following diagnostic tools is most appropriate for assessing the prognosis of this patient with CML?",
      "options": [
        {
          "label": "A",
          "text": "Karnofsky's performance status",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sokal risk score",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ann Arbor staging classification",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rai classification",
          "correct": false
        }
      ],
      "correct_answer": "B. Sokal risk score",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:469px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Risk</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Sokal score</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Low</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><0.8</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Intermediate</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>0.8-1.2</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>High</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>>1.2</p>\n</td>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:581px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Hasford score</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>European Treatment and Outcome Study (EUTOS) Score</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Modification of Sokal score takes into addition two more values:</p>\n<ul>\n<li>Eosinophil count.</li>\n<li>Basophil count.</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Two parameters:</p>\n<ul>\n<li>Spleen size.</li>\n<li>Basophil count.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "fbda7b2d"
    }
  ]
}